UB Paderborn / Katalog / Suche / in CDI

1 – 12 von 12

Sortiert nach

Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9312-9318

2005

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

Journal of clinical oncology, 2023-03, Vol.41 (7), p.1376-1382

2023

Link zum Volltext

Verfügbarkeit prüfen

Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4674-4682

2010

Link zum Volltext

Verfügbarkeit prüfen

Multidisciplinary Management of Breast Cancer With Extensive Regional Nodal Involvement

Journal of clinical oncology, 2020-07, Vol.38 (20), p.2290-2298

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1078-1087

2005

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous Image-Guided Radiofrequency Ablation of Painful Metastases Involving Bone: A Multicenter Study

Journal of clinical oncology, 2004-01, Vol.22 (2), p.300-306

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

Journal of clinical oncology, 2006-02, Vol.24 (4), p.552-562

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)

Journal of clinical oncology, 2022-02, Vol.40 (5), p.449-458

2022

Link zum Volltext

Verfügbarkeit prüfen

SERENA-4: A phase 3 comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive, HER2-negative advanced breast cancer who have not previously received systemic treatment for advanced disease

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS1101-TPS1101

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial

Journal of clinical oncology, 2023-11, Vol.41 (33), p.5118

2023

Link zum Volltext

Verfügbarkeit prüfen

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2664-2672

2003

Link zum Volltext

Verfügbarkeit prüfen

Troxacitabine, an l-stereoisomeric nucleoside analog, on a five-times-daily schedule: A phase I and pharmacokinetic study in patients with advanced solid malignancies

Journal of clinical oncology, 2002, Vol.20 (1), p.96-109

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 12 von 12

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

KollektionOxford University Press Journals Current

KollektionIngentaConnect Journals

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)
Japanisch
(2)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes

Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

Multidisciplinary Management of Breast Cancer With Extensive Regional Nodal Involvement

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer

Percutaneous Image-Guided Radiofrequency Ablation of Painful Metastases Involving Bone: A Multicenter Study

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)

SERENA-4: A phase 3 comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive, HER2-negative advanced breast cancer who have not previously received systemic treatment for advanced disease

Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Troxacitabine, an l-stereoisomeric nucleoside analog, on a five-times-daily schedule: A phase I and pharmacokinetic study in patients with advanced solid malignancies

Aktive Filter

Suchergebnisse filtern